EUVIMEDEUVIMED entdecken
Crossref

CD169 expression on monocytes as a marker for assessing type I interferon status in pediatric inflammatory diseases

Naoto Sakumura, Tadafumi Yokoyama, Masaaki Usami, Yuiko Hosono, Natsumi Inoue, Yusuke Matsuda, Yuko Tasaki, Taizo Wada

Clinical Immunology · 2023-05 · 250 · 109329

DOI: 10.1016/j.clim.2023.109329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2023-05. Verfasst von Naoto Sakumura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Bacterial Infections, Interferon Type I, Lupus Erythematosus, Systemic, Virus Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Morinaga Foundation For Health and Nutrition.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evaluation of type I interferons (IFNs) in inflammatory or autoimmune diseases is challenging because of their rapid clearance in peripheral blood. The IFN gene expression signature has recently been used to evaluate the IFN status; however, this is often a labor-intensive and time-consuming procedure. Therefore, we assessed the feasibility of measuring expression of an IFN-inducible protein, CD169 (Siglec-1), on monocytes and circulating levels of soluble CD169 as alternative markers for type I IFN status in various pediatric inflammatory diseases. METHODS: Data from flow cytometric analysis of surface CD169 on monocytes and an enzyme-linked immunosorbent assay of soluble CD169 in peripheral blood were compared with serum IFN-α levels in 8 patients with viral infections, 5 with bacterial infections, 10 with systemic lupus erythematosus (SLE), 5 with Kikuchi-Fujimoto disease (KFD), 7 with Kawasaki disease (KD), and 8 with inflammatory bowel disease (IBD), and in 8 healthy controls. RESULTS: Surface CD169 expression was detected mainly on CD14+ monocytes and was significantly increased in patients with viral infections, SLE, and KFD, but not in patients with bacterial infections, KD, and IBD. There were similar trends for circulating soluble CD169; however, there was a significant increase only in patients with viral infections. Surface CD169 levels were significantly correlated with serum levels of IFN-α and soluble CD169. CONCLUSION: Analysis of CD169 expression on CD14+ monocytes may be useful for rapid assessment of type I IFN status for differentiation of pediatric inflammatory diseases from type 1 IFN-mediated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial InfectionsInterferon Type ILupus Erythematosus, SystemicVirus DiseasesChildHumansInterferon-alphaMonocytesSialic Acid Binding Ig-like Lectin 1

Stichwörter der Autor:innen

CD169MonocytesSoluble CD169Type I interferon

Substanzen

Interferon Type IInterferon-alphaSIGLEC1 protein, humanSialic Acid Binding Ig-like Lectin 1

Autor:innen und Institutionen

  • Department of Pediatrics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Department of Pediatrics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan. Electronic address: tadafumiy@staff.kanazawa-u.ac.jp.

Förderung

  • Morinaga Foundation For Health and Nutrition

Zitieren

APA

Sakumura, N., Yokoyama, T., Usami, M., Hosono, Y., Inoue, N., Matsuda, Y., Tasaki, Y., & Wada, T. (2023). CD169 expression on monocytes as a marker for assessing type I interferon status in pediatric inflammatory diseases. Clinical Immunology, 250, 109329. https://doi.org/10.1016/j.clim.2023.109329

Vancouver

Sakumura N, Yokoyama T, Usami M, Hosono Y, Inoue N, Matsuda Y, et al. CD169 expression on monocytes as a marker for assessing type I interferon status in pediatric inflammatory diseases. Clinical Immunology. 2023;250:109329. doi:10.1016/j.clim.2023.109329

BibTeX
@article{Sakumura2023,
  author = {Sakumura, Naoto and Yokoyama, Tadafumi and Usami, Masaaki and Hosono, Yuiko and Inoue, Natsumi and Matsuda, Yusuke and Tasaki, Yuko and Wada, Taizo},
  title = {CD169 expression on monocytes as a marker for assessing type I interferon status in pediatric inflammatory diseases},
  journal = {Clinical Immunology},
  year = {2023},
  volume = {250},
  pages = {109329},
  doi = {10.1016/j.clim.2023.109329}
}
Kostenlos starten →